Teleflex Inc (TFX)
180.14  -3.17 (-1.73%)

Teleflex Inc is a global provider of medical technology products that enhance the ability of healthcare professionals to provide high-quality patient care. The company develops a wide range of innovative solutions across various medical specialties, including surgical, critical care, and respiratory applications. Teleflex focuses on the design, manufacturing, and commercialization of devices and instruments that improve procedural outcomes, facilitate patient recovery, and enhance safety in both hospital and outpatient settings. With a commitment to advancing medical technologies, Teleflex aims to meet the evolving needs of healthcare providers and patients worldwide.

SummaryNewsPress ReleasesChartHistorical
A Look Ahead: Teleflex's Earnings Forecastbenzinga.com
Via Benzinga · October 30, 2024
Peering Into Teleflex's Recent Short Interestbenzinga.com
Via Benzinga · October 22, 2024
Where Teleflex Stands With Analystsbenzinga.com
Via Benzinga · October 14, 2024
(TFX) - Analyzing Teleflex's Short Interestbenzinga.com
Via Benzinga · September 26, 2024
How Is The Market Feeling About Teleflex?benzinga.com
Via Benzinga · August 26, 2024
Beyond The Numbers: 5 Analysts Discuss Teleflex Stockbenzinga.com
Via Benzinga · August 2, 2024
A Glimpse Into The Expert Outlook On Teleflex Through 4 Analystsbenzinga.com
Via Benzinga · July 16, 2024
(TFX) - Analyzing Teleflex's Short Interestbenzinga.com
Via Benzinga · July 11, 2024
Peering Into Teleflex's Recent Short Interestbenzinga.com
Via Benzinga · June 4, 2024
Expert Ratings For Teleflexbenzinga.com
Via Benzinga · May 3, 2024
How Is The Market Feeling About Teleflex?benzinga.com
Via Benzinga · May 2, 2024
This Medical Devices Stock Has Several Catalysts, Says Bullish Analystbenzinga.com
Teleflex gets an upgraded rating. Analyst Matt O'Brien takes it from Neutral to Overweight, and raises the price target from $205 to $245.
Via Benzinga · July 1, 2024
TFX Stock Earnings: Teleflex Beats EPS, Beats Revenue for Q1 2024investorplace.com
TFX stock results show that Teleflex beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024
(TFX) - Analyzing Teleflex's Short Interestbenzinga.com
Via Benzinga · April 15, 2024
Teleflex: Dividend Insightsbenzinga.com
Via Benzinga · February 26, 2024
Breaking Down Teleflex: 4 Analysts Share Their Viewsbenzinga.com
Via Benzinga · February 23, 2024
3 Top Stock Picks from America’s Leading SMID-Cap Fundinvestorplace.com
One of the best actively managed mutual funds to buy for SMID-Cap top stock picks is from Eaton Vance. Here are three of the top stocks.
Via InvestorPlace · February 7, 2024
Forecasting The Future: 10 Analyst Projections For Teleflexbenzinga.com
Via Benzinga · January 12, 2024
The Analyst Verdict: Teleflex In The Eyes Of 7 Expertsbenzinga.com
Via Benzinga · December 20, 2023
Analyst Expectations for Teleflex's Futurebenzinga.com
Via Benzinga · December 4, 2023
Teleflex's Ex-Dividend Date Is Tuesday, Here's What You Need To Knowbenzinga.com
Via Benzinga · November 9, 2023
Earnings Scheduled For February 22, 2024benzinga.com
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via Benzinga · February 22, 2024
Preview: Teleflex's Earningsbenzinga.com
Via Benzinga · February 21, 2024
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analystbenzinga.com
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via Benzinga · January 23, 2024
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · December 20, 2023